SB1773

CONTROLLED SUB-FENTANYL

Chamber Passed·4/30/25

Amends the Illinois Controlled Substances Act to update definitions and schedules.

SB1773 amends the Illinois Controlled Substances Act by updating definitions and schedules. It adds xylazine as a Class III controlled substance and modifies the list of controlled substances. The bill defines terms such as "isomer," "controlled substance," and "counterfeit substance." It also specifies substances included in Schedules I, II, and III, including various narcotics, synthetic drugs, and hallucinogens. The changes take effect January 1, 2026.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the Senate · 49–1 · Apr 30, 2025
Current
Rules Committee
Next
House floor vote

Sponsors

DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
35
18
RRRRRRRRRRRRRRRRRR
Democratic CaucusRepublican Caucus

Roll Call Votes

Third Reading in Senate

49 Yea

DRDRRDRDRRRDRDDDRRDRDDDDDRDDDDDDDDRDDDDDRDRRDRDRD

1 Nay

D

9 Not Voting

DDRDDDDDD

Calendar

May 29, 2025

2:00 PM

Judiciary - Criminal Committee Hearing

May 9, 2025

8:00 AM

Judiciary - Criminal Committee Hearing

History

Jun 2

House

Rule 19(a) / Re-referred to Rules Committee

May 31

House

Third Reading/Final Action Deadline Extended-9(b) June 2, 2026

May 28

House

Added Alternate Co-Sponsor Rep. Will Guzzardi